Delivery Order SPE2DB22D3301-SPE2DB24FX3HW
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The firm-fixed-price delivery order, valued at $3,003.51, has a completion date of February 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,837.76 for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product. The contract has a ceiling value of $6,007.02 and is a Firm Fixed Price Delivery Order with a completion date of July 10, 2025. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp is the prime...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has a ceiling value of $14,732.05 and an ultimate completion date of February 12, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier of pharmaceutical products and medical supplies to various government agencies, particularly the Department...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $10,795.98, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a specialty medication. The contract is a Firm Fixed Price Delivery Order, with a completion date of September 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $2,764.97, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 16, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $3,568.00. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Vivitrol 380 mg vials and diluents. The contract has a ceiling value of $2,154.16 and runs through February 13, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a for-profit pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery...
- This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a specialty pharmaceutical product, with a ceiling value of $39,136.27. The contract has a firm fixed price and is set to be completed by September 17, 2024. Amerisourcebergen Drug Corp is a for-profit pharmaceutical distribution and healthcare solutions...
- The federal contract award is for the delivery of Vivitrol 380 mg vials and diluents to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $9,145.90. The contract is a delivery order and has a firm fixed price pricing type, with an ultimate completion date of December 1, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FX3HWDelivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product, with a ceiling value of $15,993.12. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also a for-profit organization. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 10/9/23 |